ELTP · Elite Pharmaceuticals Inc /Nv/

$0.38 -0.01 (-1.32%) At close · Jul 28

Market Cap

$403.95M

1.08B

Total shares sold short and not yet covered, reported to FINRA by broker-dealers twice a month. Each reading settles on the 15th and the last business day of the month and is published seven business days later — the next scheduled dates are listed at the top of the table. Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score

38/100

Short interest 0.2% of shares — P27 Days to cover 1.9 — P35 Price vs VWAP +2.5% — P66 Short-volume trend +3.3% — P55 Short interest change -2.1% — P40 Worst FTD 0.00% of shares — P6

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-15). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All

Short Interest History

Settlement Date	Current Position	Previous Position	Change	Avg Daily Volume	Days to Cover
2026-08-14 Scheduled FINRA publishes Aug 25	—	—	—	—	—
2026-07-31 Scheduled FINRA publishes Aug 11	—	—	—	—	—
2026-07-15	2,599,593	2,654,887	-55,294	1,374,766	1.89
2026-06-30	2,654,887	2,594,622	+60,265	1,292,903	2.05
2026-06-15	2,594,622	2,599,516	-4,894	1,697,979	1.53
2026-05-29	2,599,516	2,622,325	-22,809	801,138	3.24
2026-05-15	2,622,325	2,473,767	+148,558	1,004,470	2.61
2026-04-30	2,473,767	2,435,723	+38,044	1,161,831	2.13
2026-04-15	2,435,723	2,449,194	-13,471	673,209	3.62
2026-03-31	2,449,194	2,298,661	+150,533	1,210,813	2.02
2026-03-13	2,298,661	2,449,531	-150,870	1,503,842	1.53
2026-02-27	2,449,531	2,538,952	-89,421	2,254,941	1.09
2026-02-13	2,538,952	2,098,448	+440,504	1,518,433	1.67
2026-01-30	2,098,448	2,155,786	-57,338	1,431,678	1.47
2026-01-15	2,155,786	2,198,798	-43,012	929,820	2.32
2025-12-31	2,198,798	2,207,729	-8,931	1,315,281	1.67
2025-12-15	2,207,729	2,229,689	-21,960	1,094,826	2.02
2025-11-28	2,229,689	2,365,428	-135,739	2,201,892	1.01
2025-11-14	2,365,428	2,128,899	+236,529	1,345,432	1.76
2025-10-31	2,128,899	2,106,780	+22,119	1,261,583	1.69
2025-10-15	2,106,780	2,265,901	-159,121	1,519,747	1.39
2025-09-30	2,265,901	2,210,633	+55,268	2,066,543	1.10
2025-09-15	2,210,633	2,521,859	-311,226	2,761,915	1.00
2025-08-29	2,521,859	2,355,954	+165,905	5,163,195	1.00
2025-08-15	2,355,954	2,475,220	-119,266	2,817,222	1.00
2025-07-31	2,475,220	2,449,782	+25,438	1,587,212	1.56

Showing 1–24 of 24 settlements

Key facts CIK 1053369 CUSIP 28659T200 Visit website Investor relations